Association between genetic variations in tumor necrosis factor receptor genes and survival of patients with T-cell lymphoma.
- Author:
Kan ZHAI
1
;
Jiang CHANG
;
Chen WU
;
Ning LU
;
Li-Ming HUANG
;
Tong-Wen ZHANG
;
Dian-Ke YU
;
Wen TAN
;
Dong-Xin LIN
Author Information
- Publication Type:Journal Article
- MeSH: Female; Genetic Variation; Genotype; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell; genetics; mortality; Male; Middle Aged; Polymorphism, Single Nucleotide; Proportional Hazards Models; Receptors, Tumor Necrosis Factor; classification; genetics; Survival Rate
- From:Chinese Journal of Cancer 2012;31(7):335-341
- CountryChina
- Language:English
- Abstract: The prognosis of T-cell lymphoma (TCL) has been shown to be associated with the clinical characteristics of patients. However, there is little knowledge of whether genetic variations also affect the prognosis of TCL. This study investigated the associations between single nucleotide polymorphisms(SNPs) in tumor necrosis factor receptor superfamily(TNFRSF) genes and the survival of patients with TCL. A total of 38 tag SNPs in 18 TNFRSF genes were genotyped using Sequenom platform in 150 patients with TCL. Kaplan-Meier survival estimates were plotted and significance was assessed using log-rank tests. Cox proportional hazard models were used to analyze each of these 38 SNPs with adjustment for covariates that might influence patient survival, including sex and international prognostic Index score. Hazard ratios (HRs) and their 95% confidence intervals(CIs) were calculated. Among the 38 SNPs tested, 3 were significantly associated with the survival of patients with TCL. These SNPs were located at LTβR (rs3759333C>T) and TNFRSF17(rs2017662C>T and rs2071336C>T). The 5-year survival rates were significantly different among patients carrying different genotypes and the HRs for death between the different genotypes ranged from 0.45 to 2.46. These findings suggest that the SNPs in TNFRSF genes might be important determinants for the survival of TCL patients.
